Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special Article: Advanced therapy medicinal products in Brazil: regulatory panorama

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Special Article: Advanced therapy medicinal products in Brazil: regulatory panorama

Advanced therapy medicinal products, considered special medications, requires Anvisa approval for use and commercialization in Brazil. They include the advanced cellular therapy products, tissue engineering products and gene therapy products, which due to their complexity involve innovation and risk...

Full description

Saved in:
Bibliographic Details
Main Authors: João Batista Silva Junior, Antonio Alfredo Rodrigues e Silva, Francielli Cristine Cunha Melo, Melina Cossote Kumoto, Renata Miranda Parca
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
Gene therapy
Advanced therapy medicinal product
Anvisa
Clinical trials
Regulatory approval
Diseases of the blood and blood-forming organs
RC633-647.5
Online Access:https://doaj.org/article/2f80208415ca4fd091bc2f52a997b650
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/2f80208415ca4fd091bc2f52a997b650

Similar Items